Benchmark Rating and PT Updates 7/29

Benchmark made a number of rating and price target updates in a research report published today.

CryoLife (NYSE: CRY) had its rating upgraded from Hold to Buy. Its price target was maintained at $6.50. On Thursday, CRY lost 1.99% of its value to finish the day at $5.42.

Expedia (NASDAQ: EXPE) had its rating reiterated at Hold. At the same time, its price target was raised from $34 to $36. On Thursday, EXPE lost 2.59% of its value to finish the day at $28.99. Its shares rebounded in today's pre-market trading, rising 5.45% to stand around $30.57.

Meredith (NYSE: MDP) had its rating reiterated at Hold. At the same time, its price target was reduced from $35 to $33. On Thursday, MDP lost 0.41% of its value to finish the day at $29.01.

RTI Biologics (NASDAQ: RTIX) had its rating upgraded from Hold to Buy. At the same time, its price target was raised from $3 to $4. On Thursday, RTIX added 8.72% to its value to end the day at $3.24.

STEC (NASDAQ: STEC) had its rating downgraded from Buy to Hold. At the moment, the rating agency does not have a price target placed on the company's stock. On Thursday, STEC added 1.18% to its value to finish the day at $16.70. Its shares are having a disastrous session in today's pre-market trading, slumping 35.69% to stand around $10.74.

True Religion Apparel (NASDAQ: TRLG) had its rating reiterated at Buy. At the same time, its price target was raised from $34 to $38. On Thursday, TRLG added 4.58% to its value to finish the day at $29.71. Its shares continued to climb in today's pre-market trading, rising 8.01% to stand around $32.09.

Valassis Communications (NYSE: VCI) had its rating reiterated at Buy. At the same time, its price target was raised from $38 to $37. On Thursday, VCI lost 6.88% of its value to finish the day at $27.75.